Lung Cancer
Share this page:
The CyberKnife® Radiosurgery Solution: Early stage Bronchogenic Carcinoma
Conclusion
Definitive surgery remains the “gold standard” for resectable early stage bronchogenic carcinoma in healthy patients. For early stage patients that are “medically unresectable” though, the CyberKnife® device is uniquely suited to deliver a tissue ablative radiation dose to a moving target lesion in the thorax, while preserving the maximum possible adjacent tissue, making it an ideal device to treat these patients.
Non-Small-Cell Carcinoma
Written by Donald B. Fuller, M.D. – Radiation Oncologist